ACMA Think Tank Series: AI In Medical Affairs Live Stream (113 minutes)

Think Tank Video
|
IACET Logo

Pioneering the Future of the Pharmaceutical Industry

What's included?
  • - About 2 hours of unedited footage to exclusive insights from the leading minds in the pharma and biotech industry.
  • - A deep dive into all aspects of AI in the life sciences, with a particular focus on medical affairs
  • - Gives key understanding of what pharma is using AI for and how to implement effectively & compliantly

$999.99
$1299.99
bestSellerBadge

Access to the full think tank video

Looking for the think tank report? Click here to purchase the ACMA Think Tank Series: AI In Medical Affairs Report (40+ pages)

Think tank target audience

C-suite pharma/biotech/life sciences industry

Directors/VP Medical Affairs

Technology/AI officers & leaders

Directors/VP Market Access

Healthcare System Administrators

Pioneering the Future of the Pharmaceutical Industry

acma think tank participant img

Topics covered in think tank

  • Evolving Landscape of AI in Medical Affairs
  • Leadership Perspectives on AI Adoption
  • Collaborative Development of AI Tools
  • Scaling AI Initiatives
  • Ensuring Trust and Accuracy

ACMA Think Tank Series: AI In Medical Affairs Live Stream (113 minutes)

Harnessing the Healthcare Data Deluge for Informed Medical Affairs

The amount of healthcare data available is estimated to have reached 2 zettabytes, or 2 trillion gigabytes, in 2022. This explosion in data provides a unique opportunity for better medical affairs decision making.

Navigating the Evolution of AI Integration in Medical Affairs

How is the discussion surrounding the integration of AI evolving within medical affairs teams?

Addressing AI Adoption Concerns in Medical Affairs

In adopting AI, what are the primary concerns and considerations voiced by medical affairs leaders, and how are these challenges being addressed?

Stakeholder Collaboration in AI-Enabled Evidence Generation

By 2030, it's anticipated that AI tools will be able to scan internal and external databases for signal detection and trial design. In the development of such evidence-generation tools, which stakeholders do you believe should be involved?

Medical Affairs Teams

AI impact on medical information teams

acma-img

Shaping the Future

For nearly a decade, ACMA has set the standards of excellence in pharmaceutical practice.

Our Think Tank Series embodies our commitment to research and innovation, focusing on how to best leverage technology and data to inform decision-making processes.

About the ACMA Think Tank

Founded on the principle of fostering excellence within the pharmaceutical industry, ACMA Think Tank is dedicated to offering unparalleled expertise. By assembling a distinguished community of thought leaders from the world's leading pharmaceutical companies, we ensure access to groundbreaking insights and the latest advancements in medical science.